Skip to Content

Join the 'Cardiovascular Risk Reduction' group to help and get support from people like you.

Cardiovascular Risk Reduction Support Group


Our support group for Cardiovascular Risk Reduction has 9 questions and 13 members. Updated 25 Apr 2017.

Popular Questions

View more questions...

Further Information

Related Condition Support Groups

Prevention of Cardiovascular Disease

Related Drug Support Groups

Victoza, simvastatin, ramipril, Micardis, Zocor, telmisartan, liraglutide, Repatha, Jardiance, view more... Praluent, Altace, alirocumab, empagliflozin, evolocumab, simvastatin / sitagliptin, Juvisync, Repatha Pushtronex, FloLipid

Popular Drugs for Cardiovascular Risk Reduction

Related Condition Guides

Latest News

FDA Approves Xarelto (rivaroxaban) to Reduce the Risk of Major Cardiovascular Events in Patients with Chronic Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD)

TITUSVILLE, NJ, October 11, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) to ...

Read more news...

Latest Questions

Ramipril - Rampiril and high bleed pressure?

Posted 25 Apr 2017 1 answer

Telmisartan 80 for high BP?

Posted 25 May 2014 1 answer

View more questions...

Top Group Members

11,336 total answers
14,354 answers
3,753 answers
93 answers
Kishan V...
81 answers
4 answers

Ask a Question